French Introduce Time Limit For Drug Approval Applications After Compassionate-Use Award
Executive Summary
Companies wanting to make their unapproved products available to patients under the “temporary use authorization” are facing some changes to the way the rules are implemented.
You may also be interested in...
Patient Groups Recommend Overhaul For Failing EU Compassionate Use Programs
An alliance of patient organizations for rare diseases says most EU member states are not doing enough to help patients with life-threatening diseases get timely access to innovative drugs on compassionate grounds. A time difference of more than three years may exist between patients benefiting from a compassionate use treatment, depending on where they live.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.